Steelers Dealing With Bout Of Stomach Flu As Preps Continue For Big Game
The Steelers are not just battling the New England Patriots this week; they're also dealing with a bout of the stomach flu.
Watch CBS News
The Steelers are not just battling the New England Patriots this week; they're also dealing with a bout of the stomach flu.
After your next trip to the doctor's office, you may be heading home with a shopping list instead of a prescription.
Wouldn't it be great if there were some really cool, unique ways to workout inside during the winter?
Pennsylvania will soon be accepting applications from those who want to grow and process medical marijuana as well as those who want to establish and run dispensaries.
Experts say there's something metallic lurking in certain foods, in our water and elsewhere that could be making us feel miserable.
A warning for parents who are using toddler chew toys, they could become infested with mold.
A Nevada woman was killed by a superbug that was found to be resistant to every antibiotic in the US.
It might sound like a bad dream, eating in your sleep with no memory of it the next day, but experts say it is a real condition with serious health consequences.
Drug store chain CVS is now offering a competitor to EpiPen, a device for self-administering injectable medicine to stop a severe allergic reaction.
The Senate has passed a measure to take the first step forward on dismantling President Barack Obama's health care law.
Should children in Allegheny County have their lead levels tested? The county Board of Health met to discuss the issue Wednesday.
The Pittsburgh AIDS Task Force wants to curve a spike in cases of syphilis in Allegheny County.
It was a major problem that will forever be associated with Flint, Mich., and now local health officials are considering mandatory lead testing for young children.
When your children are sick, are you sure you're giving them the right dose of medicine?
The Pennsylvania-based maker of Cold-Eeze throat lozenges has announced that it has sold the brand to another pharmaceutical company for $50 million.